Lise Pedersen is a journalist and bilingual conference moderator (English-French) with over two decades of experience in the media industry. Her career includes an extensive tenure as a news reporter, producer, and presenter at Euronews, Europe’s leading international news channel. In 2018, Lise transitioned to specialize on moderating for a diverse range of high-profile public and private events. Alongside these engagements, Lise is a regular contributor to Variety magazine, covering film industry news and festivals across Europe.

Lise holds a Post-Graduate Diploma in Broadcast Journalism from Falmouth College of Arts, a B.A. in International Relations and German from the University of Sussex, and a French Baccalaureate.

Prof. Lotte Steuten, PhD, is Deputy Chief Executive of the not-for-profit Office of Health Economics (OHE) and the scientific and business lead for its international research-led work program. Alongside her position at OHE, Lotte is a Visiting Honorary Professor at City University of London, an associate editor for Value in Health and served as a member of the ISPOR Board of Directors. She has published >100 peer–reviewed papers.

Lotte specializes in quantitative methods for estimating the expected health and economic benefits of healthcare interventions across their lifecycle. She has applied this to various technologies and disease areas notably vaccines, antibiotics, oncology, rare diseases, ATMPs and diagnostics.

Before joining OHE, Lotte worked in Seattle (US) as an Associate Professor at the University of Washington and at the Fred Hutch Cancer Research Center. She graduated cum laude with her PhD from Maastricht University (NL).

Christi Kelsey is the SVP of Global Product Strategy for GSKs vaccine business accountable for global strategic and operational plan for GSK’s >£7B portfolio comprised of over 15 vaccines. In this role, she has worked to refocus GSK’s strategy with the aim to return the company to market leadership position and was instrumental in working cross functionally to achieve approval of the world’s first RSV vaccines for older adults. Under her leadership, Shingrix, GSKs flagship brand, has exceeded expectations supported by strong geo-expansion and life cycle management plans.

Christi brings over 25 years of broad industry experience with key roles across the Research & Development and Commercial spectrum in both biotech and pharmaceutical organizations across the US, Europe and Asia Pacific. She joined GSK in 2006 and has held leadership positions at local, global and regional levels working for Bristol-Myers Squibb, Johnson and Johnson and Cytogen, an oncology Biotech. She has established herself as a launch specialist and collaborative leader with unique experience in specialty products.

Christi joined the vaccines business from her role as Vice President and General Manager, Australia where she was recognized for returning the business to growth and building a strong, resilient culture. Prior to this, Christi was the Global Lead for GSK’s Biologics Portfolio responsible for managing a diverse global business in a key growth area for the organisation which she joined after successfully launching the NUCALA Biologics business in the US. Her early GSK career included key US based leadership roles in brand marketing where she led the breast cancer portfolio as well as sales leadership roles in the IDN space.

These experiences coupled with a background and personal passion for science have enabled Christi to be a relentless advocate for innovation and patient access. Christi holds a degree in Chemistry from The Ohio State University. She lives with her family in Belgium.

Stefania Maggi, MD, MPH, PhD Research Director, Geriatrician and Epidemiologist, with significant experience in coordinating EU and National-funded epidemiological studies. Her research focuses on the epidemiology of aging and on the analysis of the major determinants of healthy aging through the life-course, with specific interest in nutrition and Immunization.

She is a Board-Certified Geriatrician (University of Padua, Italy) and also obtained a Master in Public Health in Epidemiology and completed a two-year Post-Doctoral Training in Epidemiology, both at the Johns Hopkins University, in Baltimore, MD, USA. Dr. Maggi was the Coordinator of the Program for Research on Aging of WHO, from 1990 to 1993, based at NIA, NIH, Bethesda, MD, USA.

She is currently working as Research Director at the CNR Aging Branch-Institute of Neuroscience in Padua and coordinating the national project on “Multicomponent interventions to improve functional and cognitive wellbeing in older adults in long term care facilities” in the frame program on Aging-The National Recovery and Resilience Plan. Dr. Maggi is the author of about 500 publications in international journals of Medicine and Public Health and is Emeritus Editor in Chief of Aging Clinical and Experimental Research (Springer).